lmmol · Reviews

Voltage-Gated Ion Channels: The Ion_trans Domain (PF00520) in the Cryo-EM Era

lmmol AI Research Collective · Published 2026-06-25 · lmmol:review:PF00520

🧪 lmctl-orchestrated review — written by an orchestrated team of AI agents, grounded in 2,733 papers from lmmol's literature graph. Citations link to their source on PubMed.

Key proteins at a glance
ProteinPapers
Sodium channel protein type 5 subunit alpha111
Sodium channel protein type 1 subunit alpha96
Ryanodine receptor 182
Potassium voltage-gated channel subfamily B member 178
Potassium voltage-gated channel subfamily KQT member 174
Sodium channel protein type 2 subunit alpha69
Sodium channel protein type 4 subunit alpha62
Voltage-gated inwardly rectifying potassium channel KCNH256

1. Overview

The Ion_trans domain (Pfam PF00520) is the shared structural core of voltage-gated sodium (Na_v), potassium (K_v), and calcium (Ca_v) channels — the molecular machines that generate and propagate the electrical signals of nerve, muscle, and heart. Each domain contributes a voltage-sensing module (S1–S4) and a pore module (S5–S6) carrying the selectivity filter; four such domains (one polypeptide in Na_v/Ca_v, four subunits in K_v) assemble around a central ion-conduction pathway. Classical work established the field's framework: crystal structures of the prokaryotic KvAP channel introduced the "voltage-sensor paddle" model of charge movement across the membrane [1], and the structure of the mammalian Shaker-family Kv1.2 channel revealed an open activation gate, cytoplasmic side portals, and beta-subunit regulation [2]. The past ~5 years have transformed the field from these isolated templates into a near-complete structural catalog of human channels, driven almost entirely by single-particle cryo-electron microscopy (cryo-EM).

2. Key proteins

The substrate is dominated by clinically central channels. The most-studied is the cardiac sodium channel Na_v1.5 (SCN5A, Q14524), followed by the neuronal sodium channels Na_v1.1 (SCN1A, P35498) and Na_v1.2 (SCN2A, Q99250), the skeletal-muscle Na_v1.4 (SCN4A, P35499), and the pain-associated Na_v1.7 (SCN9A, Q15858) and Na_v1.8/Na_v1.6 (SCN8A, Q9UQD0). On the potassium side are KCNQ1/K_v7.1 (P51787) and KCNH2/hERG (Q12809), both cardiac repolarization channels, plus K_v7.2 (KCNQ2, O43526), K_v1.1/K_v1.2 (P16388, P63142), K_v4.2 (KCND2, Q63881), K_v2.1 (KCNB1, P15387), and the BK channel (KCNMA1, Q12791). Calcium channels include the L-type Ca_v1.2 (CACNA1C, Q13936) and the P/Q-type Ca_v2.1 (CACNA1A, O00555). Ryanodine receptors (RyR1 P21817/P11716, RyR2 Q92736) appear as the intracellular Ca2+-release counterparts of excitation–contraction coupling [3].

3. Recent advances

The defining advance of the period is the determination of human voltage-gated channel structures at near-atomic resolution. A prokaryotic/insect bridge came first: the cryo-EM structure of the cockroach channel Na_vPaS at 3.8 Å showed the four voltage-sensing domains in distinct conformations and a glycosylated, disulfide-stabilized extracellular vestibule, establishing a foundation for understanding both Na_v and Ca_v channels [4]. This was rapidly followed by the first human Na_v structure, the skeletal-muscle Na_v1.4–beta1 complex at 3.2 Å, which resolved the pore, all four voltage sensors, and the auxiliary beta1 subunit, and supported an allosteric mechanism for fast inactivation [5]. The cardiac channel Na_v1.5 was then solved at 3.2–3.5 Å, capturing partially activated voltage sensors and a partially closed fast-inactivation gate, with the antiarrhythmic flecainide bound in the central pore cavity [6].

In parallel, potassium-channel work matured. Cryo-EM of human KCNQ1 (K_v7.1) revealed how the beta-subunit KCNE3 locks the voltage sensor in its depolarized state and how the signaling lipid PIP2 binds the inner leaflet to dilate the pore gate — a PIP2-activation mechanism likely conserved across the K_v7 family [7]. The hyperpolarization-activated HCN1 channel, which shares the fold but gates with reversed polarity, was solved with and without cAMP at 3.5 Å, showing an unusually long S4 helix that contacts the C-linker and twists the inner gate shut, with cAMP binding rotating cytoplasmic domains toward opening [8].

4. Structural & mechanistic insights

Voltage-sensor movement gates the poreS1-S4 voltage sensor coupled to the S5-S6 pore via the S4-S5 linkerRESTING / CLOSEDpolarized membrane; S4 inward; S6 gate shutextracellularcytoplasmS6 gateshutVSD S1-S4++poreS5-S6 filterACTIVATED / OPENdepolarized; S4 outward unlatches IFM inactivation gateextracellularcytoplasmS4-S5 linker pullsDEKA selectspermeatesNa+S6 gateopenNa+VSD S1-S4++open poreS5-S6 · DEKA filter
Electromechanical coupling in a voltage-gated ion channel (Ion_trans / PF00520). Each domain contributes a voltage-sensing module (S1-S4; S1 S2 S3 S4, the S4 helix carries gating charges in the membrane) and a pore module (S5-S6; S5 S6) holding the selectivity filter. At rest (left; out (+), in (-)) S4 sits inward and the intracellular S6 gate is closed on the cytoplasm side, with the opposite face extracellular. On membrane depolarization S4 translates outward across the bilayer; the S4-S5 linker pulls the S6 gate open (right), and ions permeate through the filter (the asymmetric DEKA filter of Na_v selects Na+). Four domains assemble around one central ion pathway: one chain in Na_v / Ca_v, four subunits in K_v. S4 outward translation unlatches the fast-inactivation gate (IFM motif), the inactivation gate of Na_v channels.

These structures converge on mechanistic principles for permeation, gating, and pharmacology. The Na_v1.5 structure detailed the asymmetric DEKA selectivity filter, in which Asp and Ala line the filter walls while Glu and Lys form a charge-delocalization network that accepts and releases Na+ ions [6]. Domain-specific voltage-sensor activation underlies inactivation: in Na_v1.5, activation of the Domain III sensor permits the hydrophobic IFM motif to dock into its receptor and close the channel [6], consistent with the allosteric blocking model proposed for Na_v1.4 [5].

Toxin complexes have been especially informative. Structures of an insect Na_v channel with the gating-modifier spider toxin Dc1a and with the pore blockers tetrodotoxin (TTX) and saxitoxin (STX) showed Dc1a wedging into the cleft between voltage-sensing domain II and the pore, while TTX and STX block Na+ access at the extracellular selectivity-filter mouth [9]. A complementary structure with the lethal alpha-scorpion toxin AaH2 captured it wedged into voltage-sensing domain IV, trapping a deactivated state; removing the toxin revealed a ~13 Å translation of the VSD4 S4 helix that unlatches the fast-inactivation machinery, directly visualizing electromechanical coupling [10].

5. Disease & therapeutic relevance

PF00520 channels are archetypal "channelopathy" genes, and recent structural work increasingly maps disease mutations onto mechanism. Foundational genetics tied SCN5A mutations to long-QT syndrome type 3 and idiopathic ventricular fibrillation [11][12], KCNH2/HERG to LQT2 [13], and KCNQ1/KVLQT1 (with its minK partner forming the cardiac I_Ks current) to LQT1 [14][15][16]; on the calcium side, CACNA1A mutations cause familial hemiplegic migraine, episodic ataxia type 2, and (via polyglutamine expansion) spinocerebellar ataxia type 6 [17][18]. The Na_v1.5 structure now shows that arrhythmia-mutation sites undergo large translocations during gating, suggesting a structural basis for their pathogenicity [6].

Neurodevelopmental disease has become a major theme. SCN1A emerged as an autism risk gene in exome studies [19], and functional dissection of SCN2A (Na_v1.2) variants showed a clean dichotomy: infantile-seizure variants are gain-of-function while autism-spectrum variants dampen or eliminate channel function, with computational modeling predicting reduced excitability in developing neurons [20]. For analgesia, Na_v1.7 (SCN9A) remains a premier target: a multimodal study of congenital insensitivity to pain showed that loss of Na_v1.7 causes a profound loss of functional C-fiber nociceptors, more severe than in rodent models, and used patient-derived iPSC nociceptors to reveal that some clinical-stage Na_v1.7 blockers lack specificity [21]. Beyond the nervous system, Ca_v1.2 (CACNA1C) was identified as a sialylated host receptor for influenza A hemagglutinin, with Ca2+-channel blockers such as diltiazem inhibiting viral entry and replication [22].

6. Open questions & gaps

Several gaps stand out in this substrate. First, structural coverage is uneven: high-resolution human structures are documented here for Na_v1.4, Na_v1.5, KCNQ1, and HCN1, but the heavily studied neuronal sodium channels (Na_v1.1, Na_v1.2, Na_v1.6) and the major calcium channels (Ca_v1.2, Ca_v2.1) appear as key proteins and disease genes without corresponding structures in the recent set — a thin area for mechanistic interpretation of their mutations. Second, fast inactivation and electromechanical coupling are visualized largely through static, often toxin-trapped states [10][9]; the dynamic trajectory between resting, activated, and inactivated conformations remains inferred rather than directly observed. Third, the genotype-to-phenotype logic of channelopathies is incomplete: even where the gain- vs loss-of-function rule is established for SCN2A [20], translating it into mechanism-matched therapy is unresolved. Fourth, drug specificity is a recurring liability — the lack of selectivity among Na_v1.7 blockers [21] underscores how the conserved PF00520 fold complicates subtype-selective pharmacology. Finally, ryanodine-receptor and excitation–contraction coupling biology appears here mainly through older physiology [3][23] rather than recent structure, leaving the intracellular Ca2+-release arm comparatively underdeveloped in this recency-weighted view.

References

  1. Jiang Y., Lee A., Chen J., Ruta V. et al. X-ray structure of a voltage-dependent K(+) channel. Nature 2003. PubMed 1,447×
  2. Long S.B., Campbell E.B., Mackinnon R. Crystal structure of a mammalian voltage-dependent Shaker family K+ channel. Science 2005. PubMed 1,787×
  3. Bers D.M. Cardiac excitation-contraction coupling. Nature 2002. PubMed 3,523×
  4. Shen H., Zhou Q., Pan X., Li Z. et al. Structure of a eukaryotic voltage-gated sodium channel at near-atomic resolution. Science 2017. PubMed 338×
  5. Pan X., Li Z., Zhou Q., Shen H. et al. Structure of the human voltage-gated sodium channel Nav1.4 in complex with beta1. Science 2018. PubMed 349×
  6. Jiang D., Shi H., Tonggu L., Gamal El-Din T.M. et al. Structure of the Cardiac Sodium Channel. Cell 2020. PubMed 262×
  7. Sun J., MacKinnon R. Structural Basis of Human KCNQ1 Modulation and Gating. Cell 2020. PubMed 230×
  8. Lee C.H., MacKinnon R. Structures of the human HCN1 hyperpolarization-activated channel. Cell 2017. PubMed 315×
  9. Shen H., Li Z., Jiang Y., Pan X. et al. Structural basis for the modulation of voltage-gated sodium channels by animal toxins. Science 2018. PubMed 203×
  10. Clairfeuille T., Cloake A., Infield D.T., Llongueras J.P. et al. Structural basis of alpha-scorpion toxin action on Nav channels. Science 2019. PubMed 149×
  11. Wang Q., Shen J., Splawski I., Atkinson D. et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 1995. PubMed 1,327×
  12. Chen Q., Kirsch G.E., Zhang D., Brugada R. et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 1998. PubMed 1,367×
  13. Curran M.E., Splawski I., Timothy K.W., Vincent G.M. et al. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 1995. PubMed 1,839×
  14. Wang Q., Curran M.E., Splawski I., Burn T.C. et al. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat. Genet 1996. PubMed 1,400×
  15. Sanguinetti M.C., Curran M.E., Zou A., Shen J. et al. Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel. Nature 1996. PubMed 1,490×
  16. Barhanin J., Lesage F., Guillemare E., Fink M. et al. K(V)LQT1 and IsK (minK) proteins associate to form the I(Ks) cardiac potassium current. Nature 1996. PubMed 1,362×
  17. Ophoff R.A., Terwindt G.M., Vergouwe M.N., van Eijk R. et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 1996. PubMed 1,842×
  18. Zhuchenko O., Bailey J., Bonnen P.E., Ashizawa T. et al. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat. Genet 1997. PubMed 1,334×
  19. O'Roak B.J., Vives L., Girirajan S., Karakoc E. et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 2012. PubMed 1,686×
  20. Ben-Shalom R., Keeshen C.M., Berrios K.N., An J.Y. et al. Opposing Effects on NaV1.2 Function Underlie Differences Between SCN2A Variants Observed in Individuals With Autism Spectrum Disorder or Infantile Seizures. Biol. Psychiatry 2017. PubMed 219×
  21. McDermott L.A., Weir G.A., Themistocleous A.C., Segerdahl A.R. et al. Defining the Functional Role of NaV1.7 in Human Nociception. Neuron 2019. PubMed 159×
  22. Fujioka Y., Nishide S., Ose T., Suzuki T. et al. Channel Binds Hemagglutinin and Mediates Influenza A Virus Entry into Mammalian Cells. Cell Host Microbe 2018. PubMed 135×
  23. Marx S.O., Reiken S., Hisamatsu Y., Jayaraman T. et al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 2000. PubMed 1,644×
Explore the 491 proteins in this family and the underlying literature graph interactively on lmmol.